Biotechnology

The Department of Defense today announced 12 additional awards to bioindustrial firms via the Distributed Bioindustrial Manufacturing Program (DBIMP). This announcement brings the DBIMP to 25 awards to date totaling $42 million.

The Biden-Harris Administration announced a set of actions to accelerate U.S. domestic biomanufacturing capacity and highlighting progress in the two years since the President signed the Executive Order.

In response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration and the U.S. Department of Agriculture have developed a plan to update, streamline and clarify their regulations and oversight mechanisms for products of biotechnology.

The U.S. National Science Foundation is investing $9.75 million to advance novel solutions for complex societal and economic challenges inspired by biological systems. NSF's investment awards 15 multidisciplinary teams to Phase 1 of the NSF Convergence Accelerator's Track M: Bio-Inspired Design Innovations.

To launch the third Investing in America tour, the Biden-Harris Administration is hosting a White House convening to officially kick off its Advanced Manufacturing Workforce Sprint—an intensive drive to build a diverse, skilled pipeline of workers for good jobs, including union jobs, in advanced manufacturing.

The U.S. National Science Foundation announced the first Experiential Learning for Emerging and Novel Technologies (ExLENT) investment of $18.8 million to 27 teams at U.S. institutions of higher education. The ExLENT program aims to expand practical learning opportunities for individuals interested in entering or gaining more experience in key technologies, such as advanced manufacturing, artificial intelligence, biotechnology, quantum information science and semiconductors and microelectronics.

The Biden-Harris Administration released a new action plan to rapidly and equitably expand biotechnology and biomanufacturing education and job training programs in the United States.

President Biden signed an Executive Order (E.O.) to advance biotechnology and biomanufacturing innovation for a sustainable, safe, and secure American bioeconomy. Today’s announcements in response to the President’s E.O. will help strengthen America’s bioeconomy, rebuild our supply chains here at home, and support the nation’s innovation ecosystem. They will also help ensure we can make in the United States all that we invent in the United States.